Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer

Advanced staged high‐grade serous ovarian cancer (HGSOC) is the leading cause of gynecological cancer death in the developed world, with 5‐year survival rates of only 25–30% due to late‐stage diagnosis and the shortcomings of platinum‐based therapies. A Phase I clinical trial of a combination of fre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bioeng Transl Med
Main Authors: Mensah, Lawrence B., Morton, Stephen W., Li, Jiahe, Xiao, Haihua, Quadir, Mohiuddin A., Elias, Kevin M., Penn, Emily, Richson, Aysen K., Ghoroghchian, Paiman Peter, Liu, Joyce, Hammond, Paula T.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2019
Assuntos:
Research Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584097/
https://ncbi.nlm.nih.gov/pubmed/31249881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/btm2.10131
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares